| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 刘浩 | 华创证券 | 医药生物 | 69.94% | 50.94% | 50.73% | 20.00% | 2 | -47.33% | 2025-06-03 |
| 2 | 刘浩 | 华创证券 | 医药生物 | 69.42% | 72.47% | 19.58% | 20.00% | 2 | -47.33% | 2025-07-03 |
| 3 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 69.32% | 77.42% | 45.47% | 3.45% | 7 | -27.10% | 2025-07-08 |
| 4 | 阳景 | 浦银国际证券 | 医药生物 | 69.08% | 63.15% | 34.03% | 100.00% | 3 | 0.00% | 2025-07-30 |
| 5 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 68.59% | 64.92% | 28.13% | 3.45% | 7 | -27.10% | 2025-06-30 |
| 6 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 68.57% | 71.49% | 18.57% | 3.45% | 7 | -27.10% | 2025-07-02 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 68.37% | 77.32% | 11.86% | 20.00% | 2 | -47.33% | 2025-07-11 |
| 8 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 68.29% | 74.00% | 43.51% | 3.45% | 7 | -27.10% | 2025-07-07 |
| 9 | 刘浩 | 华创证券 | 医药生物 | 68.09% | 71.10% | 18.63% | 20.00% | 2 | -47.33% | 2025-07-04 |
| 10 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 68.03% | 64.10% | 27.04% | 3.45% | 6 | -27.10% | 2025-06-18 |
| 11 | 刘浩 | 华创证券 | 医药生物 | 67.87% | 54.91% | 33.71% | 20.00% | 2 | -47.33% | 2025-06-06 |
| 12 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.36% | 63.05% | 47.80% | 3.45% | 6 | -27.10% | 2025-05-29 |
| 13 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.14% | 67.29% | 40.00% | 3.45% | 7 | -27.10% | 2025-06-25 |
| 14 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 67.07% | 64.15% | 27.12% | 3.45% | 7 | -27.10% | 2025-06-27 |
| 15 | 唐寅灏 | 中信证券 | 医药生物 | 67.02% | 74.95% | 42.31% | 60.00% | 13 | -8.47% | 2025-07-16 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 66.16% | 50.55% | 38.97% | 20.00% | 2 | -47.33% | 2025-06-04 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.77% | 61.54% | 28.01% | 3.45% | 7 | -27.10% | 2025-06-19 |
| 18 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.76% | 63.11% | 35.39% | 3.45% | 7 | -27.10% | 2025-06-24 |
| 19 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.71% | 65.15% | 38.40% | 3.45% | 7 | -27.10% | 2025-06-26 |
| 20 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 68.73% | 35.84% | 2.86% | 0 | -56.96% | 2025-07-09 |